Former DEA Chief of Pharmaceutical Investigations leading Khiron’s best-in-class procedures to self-regulate on diversion control TORONTO, June 19, 2018 /CNW/ – Khiron Life Sciences Corp. (TSXV: KHRN), a Canadian integrated medical...

Under Mr. Murphy’s guidance, Khiron becomes only medical cannabis producer in Colombiawith DEA-level security protocols TORONTO, May 31, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN), a Canadian...